Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual Conference

<p>WARMINSTER, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following investor conference: H.C. […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/arbutus-to-present-at-h-c-wainwright-4th-annual-hepatitis-b-virus-hbv-virtual-conference/">Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>